financetom
Business
financetom
/
Business
/
HSBC to hire almost 50 bankers for startup, venture lending in US
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
HSBC to hire almost 50 bankers for startup, venture lending in US
Mar 11, 2024 7:03 AM

NEW YORK (Reuters) -HSBC ( HSBC ) is planning to recruit about 50 more bankers in its U.S. commercial bank to lend to startup companies, mainly in the technology and healthcare sectors, according to a senior executive.

The London-headquartered bank hired about 40 people from Silicon Valley Bank after the latter lender failed a year ago. The innovation banking business at HSBC ( HSBC ) now stands at about 60 employees and is focused on serving early- and mid-stage companies.

"There's this void in the market and we're jumping into it," Wyatt Crowell, head of commercial banking at HSBC ( HSBC ), told Reuters in an interview. "It's gone way better than I thought it was going to go, both in terms of the volume of deals and our win rate on the deals."

Startup companies typically struggle to get financing from major banks until they grow larger and become more established. HSBC ( HSBC ) and JPMorgan are among the lenders that are staffing up to serve startups as a way to win business in the longer term, including initial public offerings, overseas expansion, deals and wealth management.

HSBC ( HSBC ) has signed up about 250 companies as clients for the venture lending business, closed 35 lending deals and signed another 30 term sheets with clients for an average deal size of $15 million, Crowell said.

"I believe we've got traction in the market and that we're kind of punching above our weight relative to the scale of this team," he said. "And that plus our desires to take this global is what is driving the next wave of investment."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biden administration finalizes rule to strengthen mental health parity law
Biden administration finalizes rule to strengthen mental health parity law
Sep 9, 2024
NEW YORK, Sept 9 (Reuters) - The Biden Administration on Monday said it had finalized regulation to help ensure the 175 million Americans with private health insurance have access to affordable mental health services. The 2008 Mental Health Parity and Addiction Equity Act already requires insurers and corporate-backed health plans to provide access and payment structures for mental health care...
Big Lots Initiates Bankruptcy Proceedings; Agrees to Sell Assets, Business Operations to Nexus Capital
Big Lots Initiates Bankruptcy Proceedings; Agrees to Sell Assets, Business Operations to Nexus Capital
Sep 9, 2024
04:42 AM EDT, 09/09/2024 (MT Newswires) -- Big Lots ( BIG ) said Monday it has filed for Chapter 11 bankruptcy proceedings with the US Bankruptcy Court for the District of Delaware, and agreed to sell substantially all of its assets and ongoing business operations to Nexus Capital Management. Under the terms of the agreement, Nexus will serve as the...
Exxon withdraws from race to buy stake in Namibia oil block from Galp, sources say
Exxon withdraws from race to buy stake in Namibia oil block from Galp, sources say
Sep 9, 2024
LONDON, Sept 9 (Reuters) - Exxon Mobil ( XOM ) has pulled out of the race to buy half of Galp Energia's stake in a large oil discovery in Namibia that has attracted interest from top energy companies, sources with knowledge of the matter said. More than 12 oil companies including Exxon, Shell and Brazil's national oil company Petrobras had...
AstraZeneca Reports Positive Results From Phase 3 Study of Potential Lung Cancer Treatment
AstraZeneca Reports Positive Results From Phase 3 Study of Potential Lung Cancer Treatment
Sep 9, 2024
04:25 AM EDT, 09/09/2024 (MT Newswires) -- AstraZeneca ( AZN ) said Sunday its analysis of a phase 3 trial of its drug datopotamab deruxtecan showed a meaningfully greater magnitude of efficacy versus docetaxel in the treatment of patients with advanced or metastatic non-small cell lung cancer. According to the analysis, treatment with datopotamab deruxtecan reduced the risk of disease...
Copyright 2023-2026 - www.financetom.com All Rights Reserved